BIOMAT Database Logo BIOMAT Database Logo

[Improvement in anti-hemophilic preparations and its problems. 2. Inadequacy of the heat treatment of factor concentrates on the inactivation of non-A, non-B hepatitis virus]. 1988

M Inagaki, and M Osano

UI MeSH Term Description Entries
D004340 Drug Contamination The presence of organisms, or any foreign material that makes a drug preparation impure. Drug Adulteration,Drug Contamination, Chemical,Drug Contamination, Microbial,Drug Contamination, Physical,Drug Impurity,Adulteration, Drug,Chemical Drug Contamination,Chemical Drug Contaminations,Contamination, Chemical Drug,Contamination, Drug,Contamination, Microbial Drug,Contamination, Physical Drug,Contaminations, Chemical Drug,Contaminations, Microbial Drug,Contaminations, Physical Drug,Drug Adulterations,Drug Contaminations,Drug Contaminations, Chemical,Drug Contaminations, Microbial,Drug Contaminations, Physical,Drug Impurities,Impurity, Drug,Microbial Drug Contamination,Microbial Drug Contaminations,Physical Drug Contamination,Physical Drug Contaminations
D005164 Factor IX Storage-stable blood coagulation factor acting in the intrinsic pathway of blood coagulation. Its activated form, IXa, forms a complex with factor VIII and calcium on platelet factor 3 to activate factor X to Xa. Deficiency of factor IX results in HEMOPHILIA B (Christmas Disease). Autoprothrombin II,Christmas Factor,Coagulation Factor IX,Plasma Thromboplastin Component,Blood Coagulation Factor IX,Factor 9,Factor IX Complex,Factor IX Fraction,Factor Nine,Factor IX, Coagulation
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006525 Hepatitis, Viral, Human INFLAMMATION of the LIVER in humans due to infection by VIRUSES. There are several significant types of human viral hepatitis with infection caused by enteric-transmission (HEPATITIS A; HEPATITIS E) or blood transfusion (HEPATITIS B; HEPATITIS C; and HEPATITIS D). Viral Hepatitis, Human,Human Viral Hepatitides,Human Viral Hepatitis,Viral Hepatitides, Human
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013925 Thromboplastin Constituent composed of protein and phospholipid that is widely distributed in many tissues. It serves as a cofactor with factor VIIa to activate factor X in the extrinsic pathway of blood coagulation. Antigens, CD142,CD142 Antigens,Coagulation Factor III,Factor III,Tissue Factor,Tissue Thromboplastin,Blood Coagulation Factor III,Coagulin,Glomerular Procoagulant Activity,Prothrombinase,Tissue Factor Procoagulant,Urothromboplastin,Activity, Glomerular Procoagulant,Factor III, Coagulation,Procoagulant Activity, Glomerular,Procoagulant, Tissue Factor,Thromboplastin, Tissue

Related Publications

M Inagaki, and M Osano
[Improvement in anti-hemophilic preparations and arts problems. 1. Heat-treated concentrates].
May 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Inagaki, and M Osano
[Improvement in anti-hemophilic preparations and its problems. 5. Stability and oral administration of factor VIII and IX concentrates].
May 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Inagaki, and M Osano
[Improvement in anti-hemophilic preparations and its problems. 7. Present status and future aspect of anti-hemophilic preparations].
May 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Inagaki, and M Osano
Non-A, non-B hepatitis and heat-treated factor VIII concentrates.
July 1985, Lancet (London, England),
M Inagaki, and M Osano
Virus inactivation by heat treatment of lyophilized coagulation factor concentrates.
January 1989, Current studies in hematology and blood transfusion,
M Inagaki, and M Osano
Hepatitis B virus associated DNA polymerase inactivation in factor IX concentrates.
February 1986, Thrombosis research,
M Inagaki, and M Osano
[Improvement in anti-hemophilic preparations and its problems. 4. Factor VIII preparation (RCG-5) with intermediate purity and potency].
May 1988, [Rinsho ketsueki] The Japanese journal of clinical hematology,
M Inagaki, and M Osano
Hepatitis B virus, hepatitis non-A, non-B virus and hepatitis delta virus in lyophilized antihemophilic factor: relative sensitivity to heat.
January 1985, Hepatology (Baltimore, Md.),
M Inagaki, and M Osano
Inactivation of hepatitis B virus and non-A, non-B hepatitis by chloroform.
August 1983, Infection and immunity,
M Inagaki, and M Osano
Heat inactivation of human immunodeficiency virus in lyophilized factor VIII and factor IX concentrates.
July 1987, Thrombosis research,
Copied contents to your clipboard!